ENZYMATISCHE TUMORTHERAPIE

European patent · EP2147122 · In force

Register entry

Publication number
EP2147122
Application number
EP08754910
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 18, 2008
Published
Jan 27, 2010
Granted
Jul 16, 2014
Protection ends at the latest
Apr 17, 2028
Next annual fee due
Apr 30, 2027
IPC classes
C12Q 1/68 (2006.01)
A61K 38/50 (2006.01)
A61P 35/00 (2006.01)
Priority
US 913039 P 20.04.2007
PCT application
PCT/US2008/060733 18.04.2008
PCT publication
WO2008/131163 30.10.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. May 18, 2022

    Address changed

    Representative
    RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich → RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich

    Published in Swissreg on 18.05.2022

  6. Mar 6, 2021

    Transferred

    Owner
    Leadiant Biosciences Limited, 21 Holborn Viaduct, London EC1A 2DY, United Kingdom → Unikeris Limited, 333 Styal Road, Manchester M22 5LG, United Kingdom

    Published in Swissreg on 06.03.2021

  7. Sep 26, 2017

    Address changed

    Representative
    Rentsch Partner AG, Fraumünsterstrasse 9, Postfach 2441, 8022 Zürich → RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich

    Published in Swissreg on 26.09.2017

  8. Mar 22, 2017

    Address changed

    Owner
    Sigma-Tau Rare Disease Ltd, 21 Holborn Viaduct, London EC1A 2DY, United Kingdom → Leadiant Biosciences Limited, 21 Holborn Viaduct, London EC1A 2DY, United Kingdom

    Published in Swissreg on 22.03.2017

4 earlier entries
  1. Nov 19, 2015

    Transferred

    Owner
    Sigma-Tau Pharma Ltd., 21 Holborn Viaduct, EC1A 2DY London, United Kingdom → Sigma-Tau Rare Disease Ltd, 21 Holborn Viaduct, London EC1A 2DY, United Kingdom

    Published in Swissreg on 19.11.2015

  2. Oct 18, 2014

    Agent entered

    Representative
    Rentsch Partner AG, Fraumünsterstrasse 9, Postfach 2441, 8022 Zürich

    Published in Swissreg on 18.10.2014

  3. Oct 18, 2014

    Merged

    Owner
    Sigma-Tau Rare Diseases S.A., Rua dos Ferreiros no. 260, 9000-082 Funchal, Portugal → Sigma-Tau Pharma Ltd., 21 Holborn Viaduct, EC1A 2DY London, United Kingdom

    Published in Swissreg on 18.10.2014

  4. Jul 16, 2014

    Granted

    Published in Swissreg on 16.07.2014

Parties

Inventor

FILPULA, David R.

Piscataway, NJ 08854, US

SAPRA, Puja

Edison, NJ 08820, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.